SCHEMBL3721113

SCHEMBL3721113

CNc1cccc(OC(C)=O)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.64
KMT2A Q03164 2/20 0.64
LMNA P02545 2/20 0.59
CYP3A4 P08684 2/20 0.59
ALDH1A1 P00352 3/20 0.57
HTT P42858 2/20 0.57
NPC1 O15118 2/20 0.57
RAB9A P51151 2/20 0.57
TP53 P04637 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
ACHE P22303 1/20 0.54
GAA P10253 2/20 0.51
MAPT P10636 2/20 0.51
HSP90AA1 P07900 1/20 0.51
EPHX2 P34913 1/20 0.51
POLB P06746 1/20 0.48
PKM P14618 1/20 0.48
RECQL P46063 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
MAPK1 P28482 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL359762 0.84 MEN1 (0.71) MEN1KMT2ALMNACYP3A4ALDH1A1
SCHEMBL11554638 0.84 MEN1 (0.66) MEN1KMT2ALMNACYP3A4ALDH1A1
SCHEMBL28542980 0.82 MEN1 (0.69) MEN1KMT2ALMNACYP3A4ALDH1A1
SCHEMBL17028900 0.82 LMNA (0.76) MEN1KMT2ALMNACYP3A4ALDH1A1
SCHEMBL249305 0.82 LMNA (0.76) MEN1KMT2ALMNACYP3A4ALDH1A1
SCHEMBL31522633 0.81 ACHE (0.58) MEN1KMT2ALMNARAB9AACHE
SCHEMBL27864663 0.81 ACHE (0.58) MEN1KMT2ALMNACYP3A4ALDH1A1
SCHEMBL20196268 0.81 MEN1 (0.59) MEN1KMT2ALMNACYP3A4ALDH1A1
SCHEMBL9480062 0.81 MAPT (0.75) MEN1KMT2ALMNACYP3A4ALDH1A1
SCHEMBL396146 0.81 MEN1 (0.59) MEN1KMT2ALMNACYP3A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1732543-B1 TETRACYCLIC CARBOLINE DERATIVES FOR INHIBITING ANGIOGENESIS PTC THERAPEUTICS INC (US) 2017-05-10 EP disclosed
WO-2010123766-A1 DIAMIDE COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND β2 ADRENERGIC RECEPTOR AGONIST ACTIVITY THERAVANCE, INC. (US) 2010-10-28 WO disclosed